Ritalin and Irbesartan drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Ritalin and Irbesartan. Common interactions include anxiety among females and gait disturbance among males.

The phase IV clinical study analyzes what interactions people who take Ritalin and Irbesartan have. It is created by eHealthMe based on reports of 29 people who take Ritalin and Irbesartan from the FDA, and is updated regularly. You can use the study as a second opinion to make health care decisions.

Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.

On Sep, 18, 2023

29 people who take Ritalin and Irbesartan together, and have interactions are studied.

What is Ritalin?

Ritalin has active ingredients of methylphenidate hydrochloride. It is often used in attention deficit hyperactivity disorder. eHealthMe is studying from 28,561 Ritalin users for its effectiveness, alternative drugs and more.

What is Irbesartan?

Irbesartan has active ingredients of irbesartan. It is often used in high blood pressure. eHealthMe is studying from 33,691 Irbesartan users for its effectiveness, alternative drugs and more.

Number of Ritalin and Irbesartan reports submitted per year:

Common Ritalin and Irbesartan drug interactions by gender *:

female:

Anxiety
Dizziness
Fall
Fatigue
Headache
Depressed mood
Dysarthria
Dysphagia
Dyspnoea
Embolism arterial

male:

Gait disturbance
Hospitalisation
Electrocardiogram t wave inversion
Fatigue
Functional gastrointestinal disorder
Injection site bruising
Muscular weakness
Musculoskeletal stiffness
Plasma cell myeloma
Pre-existing condition improved

Common Ritalin and Irbesartan drug interactions by age *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

Electrocardiogram t wave inversion

50-59:

n/a

60+:

Fall
Fatigue
Embolism arterial
Facial paralysis
Injury
Peripheral swelling
Sleep disorder
Spinal pain
Transient ischaemic attack
Unresponsive to stimuli

Common conditions people have *:

Narcolepsy (brain's inability to regulate sleep-wake cycles normally): 11 people, 37.93%
Neuropathy Peripheral (surface nerve damage): 6 people, 20.69%
Multiple Sclerosis (a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath): 6 people, 20.69%
Cataplexy (loss of muscle tone accompanied by full conscious awareness): 5 people, 17.24%
Diabetic Neuropathy (neuropathic disorders that are associated with diabetes mellitus): 4 people, 13.79%
Depression: 3 people, 10.34%
High Blood Cholesterol: 2 people, 6.90%
Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 2 people, 6.90%
Breast Cancer: 2 people, 6.90%
Bipolar Disorder (mood disorder): 2 people, 6.90%

* Approximation only. Some reports may have incomplete information.

Do you take Ritalin and Irbesartan?

Personalize this study to your gender and age

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.

Related publications that referenced our studies

Coskun M, Adak I, "Excessive and frequent menstrual bleeding with methylphenidate in an adolescent girl with attention-deficit hyperactivity disorder", Journal of clinical psychopharmacology, 2017 Oct .
Yektas ?, Samurcu ND, Tufan AE, "Loss of Eyebrows (Madarosis) After Use of Long-Acting Methylphenidate: Case Report", Journal of Clinical Psychopharmacology, 2017 Aug .
Ersoy MA, Ersoy HT, "Manic symptoms associated with isotretinoin and methylphenidate combination: a case report", Klinik Psikofarmakoloji Bülteni-Bulletin of Clinical Psychopharmacology, 2014 Sep .
Coskun M, Adak I, Akaltun I, "Bilateral gynecomastia in a preadolescent boy while under treatment with methylphenidate and paroxetine", Journal of clinical psychopharmacology, 2014 Aug .
Adak, I., & Coskun, M. , "Symptomatic cholelithiasis associated with combined use of methylphenidate and fluoxetine in an otherwise healthy adolescent girl", Psychiatry and Clinical Psychopharmacology, 2014 Jan .
Coskun, M., & Adak, I. , "Excessive and frequent menstrual bleeding with methylphenidate in an adolescent girl with attention-deficit hyperactivity disorder", Journal of clinical psychopharmacology, 2014 Jan .
Yalcin O, Aslan AA, Sari BA, Turkbay T, "Possible methylphenidate related hoarseness and disturbances of voice quality: two pediatric cases", Klinik Psikofarmakoloji Bülteni-Bulletin of Clinical Psychopharmacology, 2012 Sep .
Lufi D, Bucherman M, Akita M, Cohen R, Sibani C, "The effect of methylphenidate on speech patterns of children with attention deficit disorder", Journal of Behavioral Health, 2012 Jan .